What is Pheast Therapeutics worth?
$154.6Mlast known valuation
Pheast Therapeutics last raised $24.6M in its Early Stage VC (Oct 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Pheast Therapeutics
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2025 | Early Stage VC | $24.6M | ▮ | ▮ |
| Jan 2022 | Later Stage VC | $75.3M | ▮ | ▮ |
How Pheast Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Pheast Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Pheast Therapeutics worth?
- Pheast Therapeutics's last known valuation is $154.6M.
- How much has Pheast Therapeutics raised?
- Pheast Therapeutics has raised $100.6M in total funding across 2 recorded rounds.
- When did Pheast Therapeutics last raise?
- Pheast Therapeutics last raised in Oct 2025 (Early Stage VC), raising $24.6M.